<?xml version="1.0" encoding="UTF-8"?>
<p>L-dioxolane thymidine derivatives were described as a potent class of anti-EBV agents and their anti-herpesvirus activity was dependent on viral TK. The HDVD analog (1-[(2
 <italic>S</italic>,4
 <italic>S</italic>-2-(hydroxymethyl)-1,3-dioxolan-4-yl]5-vinylpyrimidine-2,4(1H,3H)-dione) and its oral prodrug demonstrated also efficacy in a mouse model of MHV-68 (a surrogate of EBV), reducing viral replication in the lungs [
 <xref rid="B32-cancers-10-00197" ref-type="bibr">32</xref>].
</p>
